Alcohol Drinking: Clinical Trials

14 trials for Alcohol Drinking, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 active not recruiting. 14 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 114Completed 12, Active not recruiting 2

Follow Alcohol Drinking: new trials by email Literature Review of Alcohol Drinking trials Research Report on Alcohol Drinking

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study
[18F]NOS - Alcohol Use Disorder
Early Phase 1Active not recruitingUniversity of Pennsylvania42023-08-082025-11-26
Social Effects of Alcohol
Alcohol, Placebo - Alcohol Drinking
Early Phase 1CompletedUniversity of Chicago372023-02-202024-01-24
Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking
Hydrocortisone 20 MG, Placebo - Alcohol Drinking, Drinking Behavior
Early Phase 1CompletedYale University272021-05-122022-06-02
Imaging Glutamate Release From Alcohol
Alcohol - Alcohol Drinking
Early Phase 1CompletedYale University82020-03-012024-10-09
Measuring the Neuroimmune Response to Alcohol
Oral Alcohol Challenge - Alcohol Drinking
Early Phase 1CompletedYale University142019-06-202023-11-07
Behavior Brain Responses
Ethanol, Placebo - Alcohol Drinking, Drinking Behavior
Early Phase 1CompletedUniversity of Chicago302019-05-282025-01-31
Behavioral Alcohol Responses (BAR) Study
Alcohol, Placebo - Alcohol Drinking, Alcohol Use Disorder
Early Phase 1Active not recruitingCarnegie Mellon University7822018-02-132025-02-12
Alcohol, Behavior, and Brain Imaging
Ethanol, Placebo - Alcohol Drinking, Binge Drinking
Early Phase 1CompletedUniversity of Chicago802016-01-012022-04-25
Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence
Alcohol beverage, Placebo beverage - Domestic Violence, Alcohol Consumption
Early Phase 1CompletedUniversity of New Mexico422015-09-272024-10-15
Varenicline + Prazosin for Heavy Drinking Smokers
Varenicline, Prazosin, Placebo - Cigarette Smoking, Alcohol Use Disorders
Early Phase 1CompletedYale University52014-07-012020-03-12
Identification of Biomarkers for Acute Intake of Beer and Alcohol and Acute Effects on Plasma and Insulin Response
Beverage sequence ABCD, Beverage sequence CADB, Beverage sequence DACB - Alcohol Consumption, Insulin Resistance
Early Phase 1CompletedUniversity of Copenhagen192013-05-012015-05-20
Doxazosin an a1 Antagonist for Alcohol Dependence
Doxazosin, Placebo - Alcohol Dependence, Anxiety
Early Phase 1CompletedBrown University412011-11-012025-08-18
Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans
Nicotine, Ethanol - Alcohol Consumption, Tobacco Use
Early Phase 1CompletedYale University182007-01-012014-07-08
Pilot Study on Mindfulness for Tobacco and Alcohol in University Students
Mindfulness Training for Smokers, Interactive Learning for Smokers - Nicotine Dependence, Alcohol Use
Early Phase 1CompletedUniversity of Wisconsin, Madison552006-09-012014-06-24

Narrower conditions

Alcoholism (4)  ·  Drinking Behavior (3)  ·  Binge Drinking (2)  ·  Alcoholic Intoxication (1)  ·  Anxiety Disorders (1)  ·  Cigarette Smoking (1)  ·  Insulin Resistance (1)  ·  Smoking (1)  ·  Smoking Cessation (1)  ·  Substance-Related Disorders (1)  ·  Tobacco Use (1)  ·  Tobacco Use Disorder (1)

Broader conditions

Behavior (14)  ·  Drinking Behavior (11)  ·  Chemically-Induced Disorders (6)  ·  Mental Disorders (6)  ·  Alcohol-Related Disorders (5)  ·  Substance-Related Disorders (5)  ·  Glucose Metabolism Disorders (1)  ·  Health Behavior (1)  ·  Hyperinsulinism (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Smoking (1)  ·  Tobacco Smoking (1)  ·  Tobacco Use (1)

Interventions

Ethanol (8)  ·  Control Groups (1)  ·  Doxazosin (1)  ·  Fluorine-18 (1)  ·  Hydrocortisone (1)  ·  Lactose (1)  ·  Nicotine (1)  ·  Prazosin (1)  ·  Varenicline (1)

Sponsors

Yale University (5)  ·  University of Chicago (3)  ·  Brown University (1)  ·  Carnegie Mellon University (1)  ·  University of Copenhagen (1)  ·  University of New Mexico (1)  ·  University of Pennsylvania (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (12)  ·  Denmark (1)

Top investigators

Ansel T Hillmer, Ph.D. (2)  ·  Harriet de Wit (2)  ·  Brandi C Fink, Ph.D. (1)  ·  Deepak C D'Souza, M.D. (1)  ·  Elizabeth V Goldfarb, PhD (1)  ·  Eric D. Claus, Ph.D. (1)  ·  Jacob Dubroff, MD, PhD (1)  ·  James M Davis, MD (1)  ·  Jessica Weafer (1)  ·  Lars O. Dragsted, Professor (1)  ·  Lisa M Fucito, PhD (1)

Results publications

PMID 24006963, PMID 33201577, PMID 41370392

NIH funding

K01AA024788 (1), K05AA014715 (1), P50DA019706 (1), R01AA025936 (1), R01DA002812 (1), R21AA019994 (1), U54AA027989 (1)